Skip to main content
Equibles
QDEL logo

QDEL · QuidelOrtho Corp · Metrics

Track QDEL — free

Use QDEL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research QDEL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.08 -0.13 (-0.91%) At close · Oct 21
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$965.54M
Shares
68.58M
Volume · Oct 21 3.32M Avg daily vol (3M) 1.7M

QDEL metrics

89 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$14.08
Market cap
$965.54M

Price action

20 metrics
Price change (1W)
+1.5%
Price change (30D)
+28.7%
Price change (3M)
-15.6%
Price change (6M)
+18.3%
Price change (YTD)
-50.7%
Price change (1Y)
-52.8%
Trailing year
Price change (5Y)
-89.5%
52-week high
$35.38
52-week low
$9.96
Change from 52-week high
-60.2%
Change from 52-week low
+41.4%
Annualized volatility
91.0%
Annualized volatility (3M)
85.2%
Beta
2.5
RSI (14D)
60.6
Price vs SMA 50
+9.5%
Price vs SMA 200
-16.9%
Avg volume (3M)
1.70M
Relative volume
2.0
Average dollar volume
$22.69M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
68.58M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.4×
reciprocal yield 71.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 274.4%
P / book
0.5
reciprocal yield 182.1%
FCF yield
-21.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-107.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.7×
reciprocal yield 58.4%
EV / revenue historical average (5Y)
1.8×
reciprocal yield 56.5%
EV / EBIT historical average (3Y)
32.3×
reciprocal yield 3.1%
EV / EBIT historical average (5Y)
32.3×
reciprocal yield 3.1%
EV / EBITDA historical average (3Y)
12.9×
reciprocal yield 7.7%
EV / EBITDA historical average (5Y)
12.9×
reciprocal yield 7.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-03
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
-30.8%
Trailing 12 months
Net margin
-39.2%
Gross profit (TTM)
—
Operating profit (TTM)
−$824.70M
Net income (TTM)
−$1.05B
Trailing 12 months
Diluted EPS (TTM)
$-15.44
FCF margin
-7.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$39.26
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-12.13
EBITDA per diluted share (TTM)
$-5.46
Net income per diluted share (TTM)
$-15.41
Operating cash flow per diluted share (TTM)
$-0.83
Free cash flow per diluted share (TTM)
$-3.09
Capital expenditures per diluted share (TTM)
$2.26
R&D per diluted share (TTM)
$2.66
Stock compensation per diluted share (TTM)
$0.65
Book value per share
$28.28

Growth

11 metrics
Revenue growth YoY
+2.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.67B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.9%
Year over year · more shares
Revenue CAGR (3Y)
-5.8%
Revenue CAGR (5Y)
+10.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-59.1%
Return on assets
-18.3%
Debt / equity
1.6
Current ratio
1.4
EBITDA (TTM)
−$370.50M
Free cash flow (TTM)
−$211.20M
Quick ratio
0.8
Interest coverage
-4.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$2.77B
Latest balance sheet
Cash & equivalents
$123.40M
Total assets
$5.72B
Total debt
$2.89B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$57.20M
Capital expenditures (TTM)
$154.00M
R&D (TTM)
$180.90M
SG&A (TTM)
$770.30M
Stock compensation (TTM)
$44.20M
R&D / revenue
6.8%
Stock compensation / revenue
1.7%

Ownership (13F)

9 metrics
13F filers
248
13F filer change QoQ
+6
Institutional ownership
122.0%
Conviction holders (share of 13F filers)
1.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+0.6%
Holder tenure
11.0
Price vs estimated holder cost
-55.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
29.0%

Short interest

3 metrics
Short interest
21.8%
Latest settlement · 11.0 days to cover
Days to cover
11.0d
Short-squeeze score
80 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1906324 CUSIP 219798105 13F (30d) 26 filings 26 filers Visit website Investor relations